Market Place
Sourcing Support
Pacira Biosciences Reports First Quarter 2026 Financial Results
30 Apr 2026 //
FIRSTWORD PHARMA
Pacira Files Proxy Materials, Sends Letter to Shareholders
28 Apr 2026 //
FIRSTWORD PHARMA
Pacira BioSciences at 25th Needham Growth Conference
08 Apr 2026 //
GLOBENEWSWIRE
Pacira BioSciences to Present Real-World Data on EXPAREL
30 Mar 2026 //
GLOBENEWSWIRE
Pacira BioSciences Reaffirms Commitment to Shareholder Value
11 Mar 2026 //
GLOBENEWSWIRE
Pacira BioSciences Reports Inducement Grants Under Nasdaq Rules
06 Mar 2026 //
GLOBENEWSWIRE
Pacira to Participate in Fireside Chat at Conference
04 Mar 2026 //
GLOBENEWSWIRE
Pacira Highlights New NOPAIN Act Survey Data Conducted
12 Feb 2026 //
GLOBENEWSWIRE
Pacira To Report 2025 Financial Results On Feb 26, 2026
12 Feb 2026 //
GLOBENEWSWIRE
Pacira Biosciences Discloses Inducement Grants Per Nasdaq Lr
09 Feb 2026 //
GLOBENEWSWIRE
Pacira Partners With LG Chem To Distribute EXPAREL
13 Jan 2026 //
GLOBENEWSWIRE
Pacira Unveils 2025 Revenue Figures, Pending Audit
08 Jan 2026 //
GLOBENEWSWIRE
Pacira to Present at 44th Annual J.P. Morgan Healthcare Conf
07 Jan 2026 //
GLOBENEWSWIRE
Pacira Brings Exparel Campaign To Life With Family-Focused Event
02 Jan 2026 //
FIERCE PHARMA
Pacira Biosciences Joins PROBE Consortium For Osteoarthritis
18 Dec 2025 //
GLOBENEWSWIRE
Pacira Grants Inducements Under Nasdaq Rule 5635(c)(4)
03 Dec 2025 //
GLOBENEWSWIRE
Pacira BioSciences to Participate in Fireside Chat at Conferences
11 Nov 2025 //
GLOBENEWSWIRE
Amacathera Inks $230M Global Deal With Pacira Bio
04 Nov 2025 //
PR NEWSWIRE
Pacira To Release Q3 2025 Financial Results On Nov 6, 2025
30 Oct 2025 //
GLOBENEWSWIRE
Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Oct 2025 //
GLOBENEWSWIRE
Pacira Bio Discloses Inducement Grants per Nasdaq LR 5635(c)(4)
05 Sep 2025 //
GLOBENEWSWIRE
Pacira Bio Sciences Reports Second Quarter 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
Pacira`s Q2 2025 Financial Results to be Reported on August 5
24 Jul 2025 //
GLOBENEWSWIRE
Pacira Bio Expands Zilretta Promotion via Strategic Collaboration
22 Jul 2025 //
GLOBENEWSWIRE
Pacira BioSciences issues inducement grants per Nasdaq Rule
03 Jul 2025 //
GLOBENEWSWIRE
Pacira BioSciences Premieres Film at BIO 2025 on Pain Relief
18 Jun 2025 //
GLOBENEWSWIRE
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing
05 Jun 2025 //
GLOBENEWSWIRE
Investors in Pacira BioSciences face lawsuit
13 May 2025 //
PR NEWSWIRE
Pacira BioSciences Reports First Quarter 2025 Financial Results
08 May 2025 //
GLOBENEWSWIRE
Pacira to Report Q1 2025 Financial Results on May 8, 2025
29 Apr 2025 //
GLOBENEWSWIRE
Pacira BioSciences Announces Two-Year Efficacy Data for PCRX-201
28 Apr 2025 //
GLOBENEWSWIRE
Pacira BioSciences to Present 104-Week Efficacy Data on PCRX-201
22 Apr 2025 //
GLOBENEWSWIRE
Pacira BioSciences Reaffirms Commitment to Shareholders
17 Apr 2025 //
GLOBENEWSWIRE
Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
11 Apr 2025 //
GLOBENEWSWIRE
Pacira BioSciences to Join Fireside Chat at 24th Needham Virtual
01 Apr 2025 //
GLOBENEWSWIRE
Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
06 Mar 2025 //
GLOBENEWSWIRE
Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
27 Feb 2025 //
GLOBENEWSWIRE
Pacira BioSciences Reports 2024 Financial Results
27 Feb 2025 //
GLOBENEWSWIRE
Pacira BioSciences to Join Fireside Chat at Two March Conferences
26 Feb 2025 //
GLOBENEWSWIRE
Pacira To Report 2024 Financial Results On Feb 27
20 Feb 2025 //
GLOBENEWSWIRE
Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
06 Feb 2025 //
GLOBENEWSWIRE
Pacira Announces Updates to Board of Directors
30 Jan 2025 //
GLOBENEWSWIRE
Pacira Bio Executive Leadership Team with Two Key Appointments
21 Jan 2025 //
GLOBENEWSWIRE
Pacira Sets Five-Year Goals To Evolve Into Biopharma Organization
10 Jan 2025 //
GLOBENEWSWIRE
Pacira Bio to Present at 43rd Annual J.P. Morgan Conference
02 Jan 2025 //
GLOBENEWSWIRE
Pacira BioSciences: Inducement Grants Under Nasdaq LR 5635(c)(4)
06 Dec 2024 //
GLOBENEWSWIRE
Pacira Awarded New U.S. Patent Covering EXPAREL Composition
03 Dec 2024 //
GLOBENEWSWIRE
Pacira Reveals 104-Week Data on PCRX-201 for Knee Osteoarthritis
14 Nov 2024 //
GLOBENEWSWIRE
Pacira Bio to Participate in Chat at 2 Upcoming Health Conferences
12 Nov 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Q3 2024 Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
Pacira to Report Q3 2024 Financial Results on November 6, 2024
30 Oct 2024 //
GLOBENEWSWIRE
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
21 Oct 2024 //
GLOBENEWSWIRE
Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(C)(4)
07 Oct 2024 //
GLOBENEWSWIRE
Pacira Gets New J-Code For Exparel Starting January 2025
03 Oct 2024 //
GLOBENEWSWIRE
Pacira Comments On EXPAREL Patent Litigation Ruling
09 Aug 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Second Quarter 2024 Financial Results
30 Jul 2024 //
GLOBENEWSWIRE
Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
23 Jul 2024 //
GLOBENEWSWIRE
CMS Proposes New EXPAREL Reimbursement For Outpatient Surgery In 2025
10 Jul 2024 //
GLOBENEWSWIRE
Pacira To Participate In Fireside Chat At Jefferies Conference
30 May 2024 //
GLOBENEWSWIRE
Pacira $250M 2.125% Convertible Senior Notes Offering
10 May 2024 //
GLOBENEWSWIRE
